GoodRx Holdings, Inc.
GDRX
NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $1.2B
$3.48
▼ -1.42%
P/E
44.11
Mkt Cap
$1.2B
52-Wk Range
$1.77–$5.81
52-Week Range
$1.77 - $5.81
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 15.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Largest price comparison network with real-time data from thousands of U.S. pharmacies
- Strong consumer brand and 100+ million annual active users driving network effects
- Proprietary pricing algorithms and data analytics capabilities
- Multi-sided marketplace creating switching costs and recurring revenue
Bear Case
1 risk
- Above-average volatility (beta 1.6).
Growth
Stable outlook
Increasing consumer demand for healthcare cost transparency and savings tools
Value
Undervalued - trading well below Healthcare IT & Services peers
Momentum
Hot
+32.3% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying GDRX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 3, 2026
AUG 5, 2026
Reported EPS of $0.08 vs $0.08 consensus (+0.4% surprise). Revenue of $200.4M vs $193.2M expected (+3.7%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+0.4%
Revenue trend · last 8Q
—
—
+3%
+1%
+0%
-2%
-4%
-1%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$195.3M
$198.6M
$203.0M
$203.1M
$196.0M
$194.8M
$194.0M
$200.4M
Margins · last 8Q
Gross
89.5%
Operating
11.8%
Profit
11.2%
Wall Street consensus
4 analysts · 50% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
50%
Hold
50%
Sell
0%
Median Price Target
—
Latest: UBS · Aug 13, 2026
vs Industry
How GDRX stacks vs Medical - Healthcare Information Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related